Megavitamin B-3 therapy for schizophrenia.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D001205:Ascorbic Acid / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D010627:Phenethylamines / Q000652:urine; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy* / Q000652:urine; D012561:Schizophrenia, Childhood / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use
D009539:Nicotinic Acids; D010627:Phenethylamines; D014149:Tranquilizing Agents; D001205:Ascorbic Acid